Current Status of Cancer Nanotheranostics: Emerging Strategies for Cancer Management

Overview

Journal Nanotheranostics

Specialty Biotechnology

Date 2023 May 8

PMID 37151802

Authors

Vivek P Chavda

Avinash Khadela

Yasha Shah

Humzah Postwala

Pankti Balar

Lalit Vora

Affiliations

Soon will be listed here.

Abstract

Cancer diagnosis and management have been a slow-evolving area in medical science. Conventional therapies have by far proved to have various limitations. Also, the concept of immunotherapy which was thought to revolutionize the management of cancer has presented its range of drawbacks. To overcome these limitations nanoparticulate-derived diagnostic and therapeutic strategies are emerging. These nanomaterials are to be explored as they serve as a prospect for cancer theranostics. Nanoparticles have a significant yet unclear role in screening as well as therapy of cancer. However, nanogels and Photodynamic therapy is one such approach to be developed in cancer theranostics. Photoactive cancer theranostics is a vivid area that might prove to help manage cancer. Also, the utilization of the quantum dots as a diagnostic tool and to selectively kill cancer cells, especially in CNS tumors. Additionally, the redox-sensitive micelles targeting the tumor microenvironment of the cancer are also an important theranostic tool. This review focuses on exploring various agents that are currently being studied or can further be studied as cancer theranostics.

Citing Articles

Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.

Giordano A, Provenza A, Reverchon G, Baldino L, Reverchon E Pharmaceutics. 2024; 16(9).

PMID: 39339195 PMC: 11434863. DOI: 10.3390/pharmaceutics16091158.

Gold Nanoparticles Downregulate IL-6 Expression/Production by Upregulating microRNA-26a-5p and Deactivating the RelA and NF-κBp50 Transcription Pathways in Activated Breast Cancer Cells.

Farhana A, Alsrhani A, Alghsham R, Derafa W, Khan Y, Rasheed Z Int J Mol Sci. 2024; 25(3).

PMID: 38338683 PMC: 10855246. DOI: 10.3390/ijms25031404.

Nanotheranostics: The Fabrication of Theranostics with Nanoparticles and their Application to Treat the Neurological Disorders.

Singh A, Patel A, Chaudhary H, Yadav K, Minocha N Recent Pat Nanotechnol. 2023; 19(1):17-34.

PMID: 37464820 DOI: 10.2174/1872210517666230718115651.

References

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

Chavda V, Soni S, Vora L, Soni S, Khadela A, Ajabiya J . mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines (Basel). 2022; 10(12). PMC: 9785933. DOI: 10.3390/vaccines10122150. View

Song J, Yang X, Jacobson O, Lin L, Huang P, Niu G . Sequential Drug Release and Enhanced Photothermal and Photoacoustic Effect of Hybrid Reduced Graphene Oxide-Loaded Ultrasmall Gold Nanorod Vesicles for Cancer Therapy. ACS Nano. 2015; 9(9):9199-209. PMC: 5227595. DOI: 10.1021/acsnano.5b03804. View

Pelaz B, Alexiou C, Alvarez-Puebla R, Alves F, Andrews A, Ashraf S . Diverse Applications of Nanomedicine. ACS Nano. 2017; 11(3):2313-2381. PMC: 5371978. DOI: 10.1021/acsnano.6b06040. View

Kundu P, Singh D, Singh A, Sahoo S . Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis. Anticancer Agents Med Chem. 2019; 20(11):1288-1299. DOI: 10.2174/1871520619666190820145930. View

Dai H, Wang X, Shao J, Wang W, Mou X, Dong X . NIR-II Organic Nanotheranostics for Precision Oncotherapy. Small. 2021; 17(44):e2102646. DOI: 10.1002/smll.202102646. View

Chavda V, Balar P, Teli D, Davidson M, Bojarska J, Apostolopoulos V . Antibody-Biopolymer Conjugates in Oncology: A Review. Molecules. 2023; 28(6). PMC: 10053780. DOI: 10.3390/molecules28062605. View

Na J, Koo H, Lee S, Min K, Park K, Yoo H . Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models. Biomaterials. 2011; 32(22):5252-61. DOI: 10.1016/j.biomaterials.2011.03.076. View

Yoon H, Koo H, Choi K, Lee S, Kim K, Kwon I . Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials. 2012; 33(15):3980-9. DOI: 10.1016/j.biomaterials.2012.02.016. View

10.

Shao S, Rajendiran V, Lovell J . Metalloporphyrin Nanoparticles: Coordinating Diverse Theranostic Functions. Coord Chem Rev. 2018; 379:99-120. PMC: 6294123. DOI: 10.1016/j.ccr.2017.09.002. View

11.

Scheel J, Lee J, Sprague B, Lee C, Lehman C . Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol. 2014; 212(1):9-17. PMC: 4392403. DOI: 10.1016/j.ajog.2014.06.048. View

12.

Karathanasis E, Suryanarayanan S, Balusu S, McNeeley K, Sechopoulos I, Karellas A . Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 2009; 250(2):398-406. DOI: 10.1148/radiol.2502080801. View

13.

West C, Doughty A, Liu K, Chen W . Monitoring tissue temperature during photothermal therapy for cancer. J BioX Res. 2020; 2(4):159-168. PMC: 7575041. DOI: 10.1097/jbr.0000000000000050. View

14.

Pan J, Liu Y, Feng S . Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment. Nanomedicine (Lond). 2010; 5(3):347-60. DOI: 10.2217/nnm.10.13. View

15.

Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

16.

Wu J, Kong T, Yeung K, Shum H, Cheung K, Wang L . Fabrication and characterization of monodisperse PLGA-alginate core-shell microspheres with monodisperse size and homogeneous shells for controlled drug release. Acta Biomater. 2013; 9(7):7410-9. DOI: 10.1016/j.actbio.2013.03.022. View

17.

Chen F, Cai W . Nanomedicine for targeted photothermal cancer therapy: where are we now?. Nanomedicine (Lond). 2015; 10(1):1-3. PMC: 4299941. DOI: 10.2217/nnm.14.186. View

18.

Rand D, Ortiz V, Liu Y, Derdak Z, Wands J, Taticek M . Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma. Nano Lett. 2011; 11(7):2678-83. PMC: 3138192. DOI: 10.1021/nl200858y. View

19.

Sneider A, VanDyke D, Paliwal S, Rai P . Remotely Triggered Nano-Theranostics For Cancer Applications. Nanotheranostics. 2017; 1(1):1-22. PMC: 5298883. DOI: 10.7150/ntno.17109. View

20.

Grange C, Geninatti-Crich S, Esposito G, Alberti D, Tei L, Bussolati B . Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. Cancer Res. 2010; 70(6):2180-90. DOI: 10.1158/0008-5472.CAN-09-2821. View